---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-007402"
form_type: "8-K"
ticker: null
cik: "0001614067"
company_name: "Aridis Pharmaceuticals, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:28:21.774340+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aridis Pharma receives Nasdaq notice for failure to meet $1.00 minimum bid price

## Summary
- Received Nasdaq notice on March 10, 2023; bid price below $1.00 for 30 consecutive business days.
- Has 180 days (until September 6, 2023) to regain compliance by closing at $1.00 for 10 consecutive days.
- May qualify for second 180-day compliance period if not cured; otherwise delisting proceedings.
- Company will monitor bid price and consider available options to regain compliance.

## SEC filing metadata
- accession: 0001493152-23-007402
- form_type: 8-K
- cik: 0001614067
- company_name: Aridis Pharmaceuticals, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1614067/000149315223007402/0001493152-23-007402-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1614067/000149315223007402/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-007402
- JSON: https://secwatch.observer/filing/0001493152-23-007402.json
- Plain text: https://secwatch.observer/filing/0001493152-23-007402.txt

## Key facts
- Listing & Compliance Notices
  Aridis Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: March 10, 2023, Aridis Pharmaceuticals, Inc. (the “Company”) received written notice (the “ Notice ”) from the Nasdaq Stock Market, LLC (“ Nasdaq ”) indicating that the bid price for the Company’s common stock (the “Common Stock”), for the last 30 consecutive business days, had closed below the minimum $1.00 per share and, as a result, the Company is not in compliance with the $1.00 minimum bid price requirement for the continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2). The Notice has no effect at this time of the Common Stock, which continues to tr
  evidence_url: https://www.sec.gov/Archives/edgar/data/1614067/000149315223007402/0001493152-23-007402-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.